Certara Stock (NASDAQ:CERT)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$11.73

52W Range

$9.41 - $19.29

50D Avg

$12.48

200D Avg

$12.65

Market Cap

$1.81B

Avg Vol (3M)

$1.31M

Beta

1.60

Div Yield

-

CERT Company Profile


Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

1,487

IPO Date

Dec 11, 2020

Website

CERT Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 24
Reportable Segment$385.15M

Fiscal year ends in Dec 24 | Currency in USD

CERT Financial Summary


Dec 24Dec 23Dec 22
Revenue$385.15M$354.34M$335.64M
Operating Income$-1.73M$-40.77M$32.52M
Net Income$-12.05M$-55.36M$14.73M
EBITDA$-36.71M$23.84M$89.00M
Basic EPS$-0.08$-0.35$0.09
Diluted EPS$-0.08$-0.35$0.09

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts


Q4 24Feb 26, 25 | 5:00 PM
Q3 24Nov 06, 24 | 5:00 PM
Q2 24Aug 06, 24 | 5:00 PM

Peer Comparison


TickerCompany
EVHEvolent Health, Inc.
NRCNational Research Corporation
PRVAPrivia Health Group, Inc.
HSTMHealthStream, Inc.
HQYHealthEquity, Inc.
HCATHealth Catalyst, Inc.